Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Alzheimer's Disease |
Free Subscription
4 Alzheimer Dis Assoc Disord |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Alzheimer's Disease is free of charge.
Clinical Characterization of Veterans With Alzheimer Disease by Disease Severity
in the United States.
Alzheimer Dis Assoc Disord. 2024 May 17. doi: 10.1097/WAD.0000000000000622.
PubMed
Abstract available
Drivers of Memory Loss Underreport in Mild Cognitive Impairment Due to Alzheimer
Versus Vascular Disease.
Alzheimer Dis Assoc Disord. 2024 May 17. doi: 10.1097/WAD.0000000000000627.
PubMed
Abstract available
Evidence of Pericyte Damage in a Cognitively Normal Cohort: Association With CSF
and PET Biomarkers of Alzheimer's Disease.
Alzheimer Dis Assoc Disord. 2024 May 16. doi: 10.1097/WAD.0000000000000623.
PubMed
Abstract available
Measurement of Allostatic Load in Caregivers of Older Hispanic People With
Alzheimer Disease and Related Disorders.
Alzheimer Dis Assoc Disord. 2024 May 16. doi: 10.1097/WAD.0000000000000625.
PubMed
Abstract available
Deriving life-course residential histories in brain bank cohorts: A feasibility
study.
Alzheimers Dement. 2024;20:3219-3227.
PubMed
Abstract available
Viscous dynamics associated with hypoexcitation and structural disintegration in
neurodegeneration via generative whole-brain modeling.
Alzheimers Dement. 2024;20:3228-3250.
PubMed
Abstract available
Longitudinal normative standards for cognitive tests and composites using
harmonized data from two Wisconsin AD-risk-enriched cohorts.
Alzheimers Dement. 2024;20:3305-3321.
PubMed
Abstract available
Structural white matter properties and cognitive resilience to tau pathology.
Alzheimers Dement. 2024;20:3364-3377.
PubMed
Abstract available
Results from the long-term extension of PRIME: A randomized Phase 1b trial of
aducanumab.
Alzheimers Dement. 2024;20:3406-3415.
PubMed
Abstract available
Automatic classification of AD pathology in FTD phenotypes using natural speech.
Alzheimers Dement. 2024;20:3416-3428.
PubMed
Abstract available
Investigating reliable amyloid accumulation in Centiloids: Results from the
AMYPAD Prognostic and Natural History Study.
Alzheimers Dement. 2024;20:3429-3441.
PubMed
Abstract available
Distinct spatial contributions of amyloid pathology and cerebral small vessel
disease to hippocampal morphology.
Alzheimers Dement. 2024;20:3687-3695.
PubMed
Abstract available
20-year depressive symptoms, dementia, and structural neuropathology in older
women.
Alzheimers Dement. 2024;20:3472-3484.
PubMed
Abstract available
Peripheral HMGB1 is linked to O(3) pathology of disease-associated astrocytes and
amyloid.
Alzheimers Dement. 2024;20:3551-3566.
PubMed
Abstract available
Characterizing molecular and synaptic signatures in mouse models of late-onset
Alzheimer's disease independent of amyloid and tau pathology.
Alzheimers Dement. 2024 May 12. doi: 10.1002/alz.13828.
PubMed
Abstract available
Epidemiology and prevalence of dementia and Alzheimer's disease in American
Indians: Data from the Strong Heart Study.
Alzheimers Dement. 2024 May 15. doi: 10.1002/alz.13849.
PubMed
Abstract available
Choriocapillaris reduction accurately discriminates against early-onset
Alzheimer's disease.
Alzheimers Dement. 2024 May 15. doi: 10.1002/alz.13871.
PubMed
Abstract available
Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease
and related dementias and the impact of health-related comorbidities in a
community-dwelling cohort.
Alzheimers Dement. 2024 May 15. doi: 10.1002/alz.13835.
PubMed
Abstract available
Medial temporal lobe gray matter microstructure in preclinical Alzheimer's
disease.
Alzheimers Dement. 2024 May 15. doi: 10.1002/alz.13832.
PubMed
Abstract available
Urolithin A improves Alzheimer's disease cognition and restores mitophagy and
lysosomal functions.
Alzheimers Dement. 2024 May 16. doi: 10.1002/alz.13847.
PubMed
Abstract available
Association of plasma biomarkers of Alzheimer's disease and related disorders
with cognition and cognitive decline: The MYHAT population-based study.
Alzheimers Dement. 2024 May 16. doi: 10.1002/alz.13829.
PubMed
Abstract available
Riding the merry-go-round of racial disparities in ADRD research.
Alzheimers Dement. 2023;19:4735-4742.
PubMed
Abstract available
Association between hippocampal microglia, AD and LATE-NC, and cognitive decline
in older adults.
Alzheimers Dement. 2024;20:3193-3202.
PubMed
Abstract available
Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based
test with algorithm combining %p-tau217 and Abeta42/40 ratio to identify presence of
brain amyloid.
Alzheimers Dement. 2024;20:3179-3192.
PubMed
Abstract available
Adapting prescribing criteria for amyloid-targeted antibodies for adults with
Down syndrome.
Alzheimers Dement. 2024;20:3649-3656.
PubMed
Abstract available
APOE epsilon4 is associated with decreased synaptic density in cognitively impaired
participants.
Alzheimers Dement. 2024;20:3157-3166.
PubMed
Abstract available
The Relationship Between First Presenting Neuropsychiatric Symptoms in Older
Adults and Autopsy-Confirmed Memory Disorders.
Am J Geriatr Psychiatry. 2024;32:754-764.
PubMed
Abstract available
Cerebral Metabolic Signature of Chronic Benzodiazepine Use in Nondemented Older
Adults: An FDG-PET Study in the MEMENTO Cohort.
Am J Geriatr Psychiatry. 2024;32:665-677.
PubMed
Abstract available
gamma-Secretase Modulator BPN15606 Reduced Abeta42 and Abeta40 and Countered
Alzheimer-Related Pathologies in a Mouse Model of Down Syndrome.
Ann Neurol. 2024 May 15. doi: 10.1002/ana.26958.
PubMed
Abstract available
Cognitive Trajectories and Alzheimer Disease Biomarkers: From Successful
Cognitive Aging to Clinical Impairment.
Ann Neurol. 2024 May 15. doi: 10.1002/ana.26964.
PubMed
Abstract available
Pathogenic Potential of Eomesodermin-Expressing T-Helper Cells in
Neurodegenerative Diseases.
Ann Neurol. 2024;95:1093-1098.
PubMed
Abstract available
Characterizing dysregulations via cell-cell communications in Alzheimer's brains
using single-cell transcriptomes.
BMC Neurosci. 2024;25:24.
PubMed
Abstract available
The vascular contribution of apolipoprotein E to Alzheimer's disease.
Brain. 2024 May 15:awae156. doi: 10.1093.
PubMed
Abstract available
Single-value brain activity scores reflect both severity and risk across the
Alzheimer's continuum.
Brain. 2024 May 14:awae149. doi: 10.1093.
PubMed
Abstract available
Targeting excitatory:inhibitory network imbalance in Alzheimer's disease.
Brain. 2024 May 13:awae146. doi: 10.1093.
PubMed
From aberrant neurodevelopment to neurodegeneration: Insights into the hub gene
associated with autism and alzheimer's disease.
Brain Res. 2024;1838:148992.
PubMed
The identification of active compounds and therapeutic properties of fermented
and non-fermented red sorghum for the treatment of Alzheimer's dementia.
Exp Gerontol. 2024;192:112459.
PubMed
Abstract available
Investigating the effect of parasites (toxoplasma gondii RH strain, Leishmania
major (MRHO/IR/75/ER), and hydatid cyst) antigens on Alzheimer's disease: An in
vivo evaluation.
Exp Neurol. 2024;377:114813.
PubMed
Abstract available
Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of
Alzheimer's Disease with 2-Year Survival.
J Alzheimers Dis. 2024 May 16. doi: 10.3233/JAD-240401.
PubMed
Abstract available
Relationship Between Cerebrospinal Fluid Alzheimer's Disease Biomarker Values
Measured via Lumipulse Assays and Conventional ELISA: Single-Center Experience
and Systematic Review.
J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-240185.
PubMed
Abstract available
Pharmacologic and Nutritional Interventions for Early Alzheimer's Disease: A
Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
J Alzheimers Dis. 2024 May 17. doi: 10.3233/JAD-240161.
PubMed
Abstract available
Prognostic Power? Do the Plasma Biomarkers, Neurofilament Light and Phospho-Tau
181, Improve Prediction of Progression to Alzheimer's Disease Using a Machine
Learning Approach in the ADNI Cohort?
J Alzheimers Dis. 2024 May 14. doi: 10.3233/JAD-240126.
PubMed
Abstract available
Alterations in Synaptic Connectivity and Synaptic Transmission in Alzheimer's
Disease with High Physical Activity.
J Alzheimers Dis. 2024 May 10. doi: 10.3233/JAD-240123.
PubMed
Abstract available
Semantic Harmonization of Alzheimer's Disease Datasets Using AD-Mapper.
J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-240116.
PubMed
Abstract available
Alzheimer's Disease and Related Dementias in Muslim Women: Recommendations for
Culturally Sensitive Care.
J Alzheimers Dis. 2024 May 13. doi: 10.3233/JAD-240064.
PubMed
Abstract available
Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with
Lewy Bodies and Alzheimer's Disease.
J Alzheimers Dis. 2024 May 16. doi: 10.3233/JAD-231471.
PubMed
Abstract available
Simplifying Alzheimer's Disease Monitoring: A Novel Machine-Learning Approach to
Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental
State Examination and Functional Activities Questionnaire.
J Alzheimers Dis. 2024 May 11. doi: 10.3233/JAD-231426.
PubMed
Abstract available
Assessment of Gray Matter Microstructural Alterations in Alzheimer's Disease by
Free Water Imaging.
J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-231416.
PubMed
Abstract available
Plasma Neurofilament Light Relates to Divergent Default and Salience Network
Connectivity in Alzheimer's Disease and Behavioral Variant Frontotemporal
Dementia.
J Alzheimers Dis. 2024 May 11. doi: 10.3233/JAD-231251.
PubMed
Abstract available
Understanding Health Beliefs and Health Behaviors in Older Adults at Risk for
Alzheimer's Disease.
J Alzheimers Dis. 2024 May 13. doi: 10.3233/JAD-230977.
PubMed
Abstract available
Network Hyperexcitability in Early-Stage Alzheimer's Disease: Evaluation of
Functional Connectivity Biomarkers in a Computational Disease Model.
J Alzheimers Dis. 2024 May 15. doi: 10.3233/JAD-230825.
PubMed
Abstract available
Reporting and representation of participant demographic information in completed
Alzheimer's disease clinical trials.
J Am Geriatr Soc. 2024 May 15. doi: 10.1111/jgs.18958.
PubMed
Imbalance in Glucose Metabolism Regulates the Transition of Microglia from
Homeostasis to Disease-Associated Microglia Stage 1.
J Neurosci. 2024;44:e1563232024.
PubMed
Abstract available
Speculation on the transmissibility of Alzheimer's disease.
Lancet Neurol. 2024;23:555-556.
PubMed
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a
randomized, placebo-controlled phase 2a trial.
Nat Med. 2024 May 17. doi: 10.1038/s41591-024-02977.
PubMed
Abstract available
Genetic protection against Alzheimer disease.
Nat Rev Neurol. 2024 May 14. doi: 10.1038/s41582-024-00968.
PubMed
Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's
disease pathologies in 3xTg-AD mice.
Neurobiol Dis. 2024 May 9:106526. doi: 10.1016/j.nbd.2024.106526.
PubMed
Abstract available
Genes related to neurotransmitter receptors as potential biomarkers for
Alzheimer's disease.
Neurosci Lett. 2024;832:137816.
PubMed
Abstract available
Evaluation of knowledge and attitudes regarding Alzheimer's disease and related
dementia among medical students in Palestine: A cross-sectional study.
PLoS One. 2024;19:e0304012.
PubMed
Abstract available
Development and validation of the Michigan Chronic Disease Simulation Model
(MICROSIM).
PLoS One. 2024;19:e0300005.
PubMed
Abstract available
Thank you for your interest in scientific medicine.